Press Center
Members Only Login
Print this page
Timothy A.M. Chuter, DM, Professor Of Surgery, University Of California – San Francisco, Presented SVS Medal For Innovation In Vascular Surgery
CHICAGO (July 15, 2008) —
Dr. Timothy A.M. Chuter was presented the Society for Vascular Surgery Medal for Innovation in Vascular Surgery at the 62nd Annual Meeting of the Society for Vascular Surgery on June 6, 2008. Dr. Chuter has been a leading developer of the technology utilized in endovascular treatment of vascular disease for over 20 years. The medal recognizes individuals whose contribution has had a transforming impact on the practice or science of vascular surgery.
Dr. Chuter is a professor of surgery and the director of endovascular surgery at the University of California – San Francisco. As a pioneer of endovascular devices and techniques, Dr. Chuter has developed stents, stent-grafts, delivery systems, embolization coils, catheters, sheaths and an implantable port for the delivery of chemotherapeutic agents. He holds 23 different patents related to endovascular aortic stent-graft devices, stents, attachment systems, delivery systems and component junctions.
While the scope of his contributions alone would merit consideration for this recognition, the innovation that carries the most significance to the field of vascular surgery was his development of the first bifurcated endovascular stent-graft. The availability of a bifurcated device expanded the application of the stent-graft technique to the majority of aortic aneurysms and paved the way for further innovations designed to accommodate aneurysms involving major arterial branch points.
The bifurcated device also expanded the applicability of endoluminal aortic aneurysm repair. Vascular surgeons began to learn endovascular techniques and developed the endovascular skills that positioned them to adopt and apply other emerging endoluminal therapies for occlusive arterial disease, vascular trauma and venous disease, in all vascular beds. The device also led vascular surgeons to incorporate endoluminal techniques into routine clinical practice, as well as into all training programs.
Because of the breadth of his innovations in developing endovascular technology, as well as the impact on patients and the specialty, Dr. Chuter was awarded this recognition.
Dr. Chuter is a professor of surgery and the director of endovascular surgery at the University of California – San Francisco. As a pioneer of endovascular devices and techniques, Dr. Chuter has developed stents, stent-grafts, delivery systems, embolization coils, catheters, sheaths and an implantable port for the delivery of chemotherapeutic agents. He holds 23 different patents related to endovascular aortic stent-graft devices, stents, attachment systems, delivery systems and component junctions.
While the scope of his contributions alone would merit consideration for this recognition, the innovation that carries the most significance to the field of vascular surgery was his development of the first bifurcated endovascular stent-graft. The availability of a bifurcated device expanded the application of the stent-graft technique to the majority of aortic aneurysms and paved the way for further innovations designed to accommodate aneurysms involving major arterial branch points.
The bifurcated device also expanded the applicability of endoluminal aortic aneurysm repair. Vascular surgeons began to learn endovascular techniques and developed the endovascular skills that positioned them to adopt and apply other emerging endoluminal therapies for occlusive arterial disease, vascular trauma and venous disease, in all vascular beds. The device also led vascular surgeons to incorporate endoluminal techniques into routine clinical practice, as well as into all training programs.
Because of the breadth of his innovations in developing endovascular technology, as well as the impact on patients and the specialty, Dr. Chuter was awarded this recognition.
About the Society for Vascular Surgery
The Society for Vascular Surgery (SVS) is a not-for-profit medical society that seeks to advance excellence and innovation in vascular health through education, advocacy, research and public awareness. SVS is the national advocate for 2,600 vascular surgeons dedicated to the prevention and cure of vascular disease.
###
Society for Vascular Surgery - 633 N. St. Clair, 24th Floor; Chicago, IL 60611; Phone: 312-334-2300 or 800-258-7188; Fax: 312-334-2320; Email: vascular@vascularsociety.org
© 2009 VascularWeb. All rights reserved. Use of the VascularWeb site constitutes acceptance of all of the policies, rules and regulations for the site.
© 2009 VascularWeb. All rights reserved. Use of the VascularWeb site constitutes acceptance of all of the policies, rules and regulations for the site.